Radio-labelled fibroblast activation protein inhibitors in interstitial lung diseases - a systematic review
{{output}}
Background: Currently, no tools can monitor ongoing fibrotic activity properly, making early identification of and timely therapeutic intervention with antifibrotics in patients with progressive fibrosing interstitial lung diseas... ...
